Lv3
209 积分 2025-02-12 加入
Recipient Endothelial IRF1 mediates IFNγ-driven tissue tolerance in mouse models of acute Graft-versus-Host Disease
1天前
已关闭
Discovery and Optimization of a WRN Helicase Inhibitor Series through Structure-Guided Drug Design from a Covalent Fragment Binding Insight
5天前
已完结
Bruton tyrosine kinase inhibitors for multiple sclerosis
29天前
已完结
Re-defining progression in multiple sclerosis
29天前
已完结
From covalent to reversible: the expanding role of BTK inhibitors in chronic lymphocytic leukemia
1个月前
已完结
The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma
1个月前
已完结
Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632)
1个月前
已完结
Indolinobenzodiazepine Dimers (IGNs) as Antibody–Drug Conjugate (ADC) Payloads
1个月前
已关闭
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
2个月前
已完结
Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)
2个月前
已完结
皖公网安备34019202002308
